Globe Life (GL) Scheduled to Post Quarterly Earnings on Wednesday

Globe Life (NYSE:GLGet Rating) is scheduled to be announcing its earnings results after the market closes on Wednesday, April 20th. Parties interested in listening to the company’s conference call can do so using this link.

Globe Life (NYSE:GLGet Rating) last announced its quarterly earnings results on Wednesday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.77 by ($0.07). Globe Life had a net margin of 14.57% and a return on equity of 8.39%. The business had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same period last year, the company earned $1.74 EPS. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis.

Shares of NYSE GL opened at $102.93 on Monday. Globe Life has a 12-month low of $85.25 and a 12-month high of $108.61. The company has a market capitalization of $10.22 billion, a PE ratio of 14.26 and a beta of 1.02. The company has a debt-to-equity ratio of 0.18, a current ratio of 0.05 and a quick ratio of 0.05. The firm’s 50-day moving average is $101.15 and its two-hundred day moving average is $97.31.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 29th. Shareholders of record on Monday, April 4th will be issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 0.81%. The ex-dividend date is Friday, April 1st. This is an increase from Globe Life’s previous quarterly dividend of $0.20. Globe Life’s dividend payout ratio is 11.50%.

In related news, EVP Robert Brian Mitchell sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 9th. The shares were sold at an average price of $97.95, for a total transaction of $293,850.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Steven Kelly Greer sold 6,226 shares of the company’s stock in a transaction that occurred on Friday, February 4th. The stock was sold at an average price of $104.74, for a total transaction of $652,111.24. The disclosure for this sale can be found here. Insiders have sold 37,957 shares of company stock valued at $3,999,514 in the last ninety days. 4.62% of the stock is currently owned by company insiders.

Hedge funds have recently modified their holdings of the stock. Parametric Portfolio Associates LLC increased its position in Globe Life by 3.6% during the fourth quarter. Parametric Portfolio Associates LLC now owns 459,933 shares of the company’s stock worth $43,105,000 after purchasing an additional 16,095 shares during the last quarter. Morgan Stanley grew its stake in Globe Life by 6.2% during the second quarter. Morgan Stanley now owns 298,656 shares of the company’s stock worth $28,447,000 after buying an additional 17,374 shares during the period. Sei Investments Co. grew its stake in Globe Life by 60.1% during the fourth quarter. Sei Investments Co. now owns 11,703 shares of the company’s stock worth $1,090,000 after buying an additional 4,392 shares during the period. Metropolitan Life Insurance Co NY grew its stake in Globe Life by 17.7% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 10,761 shares of the company’s stock worth $1,009,000 after buying an additional 1,617 shares during the period. Finally, LPL Financial LLC grew its stake in Globe Life by 6.8% during the fourth quarter. LPL Financial LLC now owns 9,377 shares of the company’s stock worth $879,000 after buying an additional 600 shares during the period. 73.85% of the stock is owned by hedge funds and other institutional investors.

GL has been the topic of several recent research reports. Zacks Investment Research raised shares of Globe Life from a “sell” rating to a “hold” rating in a report on Monday, February 7th. Wolfe Research assumed coverage on shares of Globe Life in a research report on Friday, January 21st. They issued an “underperform” rating and a $85.00 price objective for the company. Piper Sandler raised shares of Globe Life from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $105.00 to $117.00 in a research report on Wednesday, January 12th. Jefferies Financial Group assumed coverage on shares of Globe Life in a research report on Tuesday, January 25th. They issued a “hold” rating and a $106.00 price objective for the company. Finally, StockNews.com assumed coverage on shares of Globe Life in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $108.33.

Globe Life Company Profile (Get Rating)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Featured Stories

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.